510(k) Report

510(k) · Cleared

Cleared

VertebraLINK Fusion Platform

K162693510(k) TraditionalCleared Mar 29, 2017183-day reviewClass II21 CFR 888.3080

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Facetlink Dba Linkspine · MAX Intervertebral Fusion Device With Bone Graft, Lumbar

Cleared on Mar 29, 2017 as substantially equivalent to K130573 (Tyber Medical, LLC, 2013) and 2 other predicates after a 183-day review. Its family tree reaches back 12 generations to 1984.

Decided
Mar 29, 2017
Review
183 days
Class
Class II
Product code
MAX
Recalls
None
Predicates
3

Its longest line of descent runs back 12 generations to K841189 (1984). 85 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 12 generations backK841189 Oec/Rezaian Spinal FixatorOrthopedic Equipment Co., Inc. · 1984
  2. 8 generations between
  3. 3 generations backK093242 Patriot Transcontinental Llif SpacerGlobus Medical, Inc. · 2009
  4. 2 generations backK102293 Caliber SpacerGlobus Medical, Inc. · 2011
  5. 1 generation backK112095 Acculif TL-Peek Ibf CageCoalign Innovations, Inc. · 2011
  6. This deviceK162693 VertebraLINK Fusion PlatformFacetlink Dba Linkspine · 2017
Show all 12 generations
  1. Root · 12 generations backK841189 Oec/Rezaian Spinal FixatorOrthopedic Equipment Co., Inc. · 1984
  2. 11 generations backK990148 Stackable Cage SystemDepuy Motech Acromed · 1999
  3. 10 generations backK003043 Surgical Titanium Mesh SystemDepuyacromed · 2001
  4. 9 generations backK020522 Modification to Surgical Titanium Mesh SystemDepuyacromed · 2002
  5. 8 generations backK030833 Depuy Acromed VBR SystemDepuyacromed · 2003
  6. 7 generations backK031635 Depuy Acromed VBR SystemDepuyacromed · 2003
  7. 6 generations backK041722 Modification to VBR Spinal SystemDepuy Spine, Inc. · 2004
  8. 5 generations backK052746 Concorde VBR Spinal SystemDepuy Spine, Inc. · 2005
  9. 4 generations backK090899 Depuy Spine Lateral SystemDepuy Spine, Inc. · 2009
  10. 3 generations backK093242 Patriot Transcontinental Llif SpacerGlobus Medical, Inc. · 2009
  11. 2 generations backK102293 Caliber SpacerGlobus Medical, Inc. · 2011
  12. 1 generation backK112095 Acculif TL-Peek Ibf CageCoalign Innovations, Inc. · 2011
  13. This deviceK162693 VertebraLINK Fusion PlatformFacetlink Dba Linkspine · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−12K841189Oec/Rezaian Spinal FixatorOrthopedic Equipment Co., Inc.1984—
−11K990148Stackable Cage SystemDepuy Motech Acromed1999—
−10K003043Surgical Titanium Mesh SystemDepuyacromed2001—
−9K020522Modification to Surgical Titanium Mesh SystemDepuyacromed2002—
−8K030833Depuy Acromed VBR SystemDepuyacromed2003—
−7K031635Depuy Acromed VBR SystemDepuyacromed2003—
−6K041722Modification to VBR Spinal SystemDepuy Spine, Inc.2004—
−5K052746Concorde VBR Spinal SystemDepuy Spine, Inc.2005—
−4K090899Depuy Spine Lateral SystemDepuy Spine, Inc.2009—
−3K093242Patriot Transcontinental Llif SpacerGlobus Medical, Inc.2009—
−2K102293Caliber SpacerGlobus Medical, Inc.2011—
−1K112095Acculif TL-Peek Ibf CageCoalign Innovations, Inc.2011—
0 (this device)K162693VertebraLINK Fusion PlatformFacetlink Dba Linkspine2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199620
199920
200010
200190
200270
200370
2004100
200580
200610
200780
200870
200930
201020
201120
201230
201310
FIG. 1 — Lineage of K162693, 1984–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MAX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MAX device

  1. #1 K203714 NuVasive Thoracolumbar Interbody Systems…score 102.5 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K130573Tyber Medical Interbody System; Acif, Alif, Plif, Tlif, Dlif
Summary page 5
…evices Trade or Proprietary or 510k Number Manufacturer Predicate Type Model Name K130573 Interbody System Tyber Medical Primary AccuLiF® TL-PEEK Cage CoAlign K…
Tyber Medical, LLC2013—
*K112095Acculif TL-Peek Ibf Cage
Summary page 5
…Model Name K130573 Interbody System Tyber Medical Primary AccuLiF® TL-PEEK Cage CoAlign K112095 Additional and AccuLiF® TL and PL Innovation…
Coalign Innovations, Inc.2011—
*K113478Plif Cage
Summary page 5
…TL-PEEK Cage CoAlign K112095 Additional and AccuLiF® TL and PL Innovation K113478 PLIF Cage Eisertech Additional Px HA™ PEEK IBF K151785…
Eisertech, LLC2012—
†K151785Px HA PEEK IBF SystemInnovasis, Inc.2015—

Also cleared against K130573: 10 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 33 years and passes through 7 companies; a new generation was cleared every 1.1 years on median.
  • 10 of the 85 ancestors have a recall of any class.
  • 10 other devices also cite its predicate K130573.

How does its category compare?

All MAX devices

MAX Intervertebral Fusion Device With Bone Graft, Lumbar: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · MAX

29in 2025

2007: 72008: 352009: 312010: 292011: 492012: 482013: 582014: 582015: 532016: 642017: 762018: 642019: 602020: 562021: 532022: 412023: 302024: 382025: 292026 (partial year): 18
2007high 76 (2017) · low 7 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MAX

85in 2025

2007: 86 days median2008: 88 days median2009: 102 days median2010: 137 days median2011: 98 days median2012: 69 days median2013: 102 days median2014: 115 days median2015: 113 days median2016: 124 days median2017: 116 days median2018: 114 days median2019: 131 days median2020: 106 days median2021: 109 days median2022: 95 days median2023: 87 days median2024: 91 days median2025: 85 days median2026 (partial year): 95 days median
2007high 137 (2010) · low 69 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MAX

5in 2025

2008: 22009: 92011: 32012: 11, 1 Class I2014: 32015: 12016: 62017: 12018: 42019: 12022: 12024: 12025: 5
2007high 11 (2012) · low 0 (2007)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · MAX

811in 2025

2007: 122008: 192009: 902010: 1542011: 2012012: 3272013: 3802014: 3662015: 5242016: 6472017: 5962018: 6162019: 6992020: 6402021: 6222022: 6182023: 5762024: 7292025: 811
2007high 811 (2025) · low 12 (2007)2025

MAUDE reports naming product code MAX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007786012
20083588219
200931102990
2010291370154
201149983201
2012486911 (1)327
2013581020380
2014581153366
2015531131524
2016641246647
2017761161596
2018641144616
2019601311699
2020561060640
2021531090622
202241951618
202330870576
202438911729
202529855811
202618950—

What is it indicated for?

The VertebraLINK Fusion Platform is indicated for use in patients with degenerative disc disease (DDD) at one or two levels from L2 to S1. These DDD patients may also have up to Grade 1 Spondylolisthesis or retrolisthesis at the involved levels. DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. These patients should be skeletally mature and have had six months of non-operative treatment.…

Read the full statement (133 words)

The VertebraLINK Fusion Platform is indicated for use in patients with degenerative disc disease (DDD) at one or two levels from L2 to S1. These DDD patients may also have up to Grade 1 Spondylolisthesis or retrolisthesis at the involved levels. DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. These patients should be skeletally mature and have had six months of non-operative treatment. These implants may be implanted via an open or a minimally invasive posterior approach. Alternatively, these implants may also be implanted via posterior and/or transforaminal approach. These implants are to be used with autogenous bone graft. These devices are intended to be used with supplemental fixation instrumentation, which has been cleared by the FDA for use in the lumbar spine.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K162693: VertebraLINK Fusion Platform.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K162693

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026